The Bahamas Launches “It’s More Bahamas Season” With $250 Instant Savings Offer to Fuel Fall Travel

Nassau, The Bahamas, July 24, 2026 (GLOBE NEWSWIRE) — The Bahamas Ministry of Tourism today unveiled its “It’s More Bahamas Season” promotion featuring a $250 instant savings incentive, offering North American travelers a high-value gateway to the islands for the upcoming autumn season. With warm island breezes, peaceful beaches, and plenty of adventures for visitors to experience, it’s an ideal time to visit The Bahamas. Travelers can spend their days swimming with pigs in the Exumas, diving vibrant reefs off Andros, exploring the pink sand beaches of Eleuthera and Harbour Island, or soaking up the energy of Nassau and Paradise Island, all just a short flight from the U.S. and Canada.

Zoomex X Space Recap With Fernando Llorente and the World Cup Final Panel

VICTORIA, Seychelles, July 24, 2026 (GLOBE NEWSWIRE) —

As part of the Zoomex World Cup Impact Pledge, Zoomex hosted the fifth and final episode of its World Cup Edition X Space. The discussion featured World Cup winner Fernando Llorente alongside football commentators Juan, Gran Mussama, and Miguel Serrano TV. The session was hosted by Fernando Lillo Aranda from Boston as anticipation built in the final hours before the World Cup Final.

Resumen de Zoomex X Space con Fernando Llorente y el Panel de la Final de la Copa del Mundo

VICTORIA, Seychelles, July 24, 2026 (GLOBE NEWSWIRE) —

Fernando Llorente afirmó que lo mejor que hizo España contra Francia fue exactamente lo que Inglaterra dejó de hacer contra Argentina. Mantuvieron la posesión del balón. Cuando tienes el balón, marcas el ritmo del partido.
• Inglaterra se puso 1-0 arriba e inmediatamente comenzó a defender su propia portería desde la línea del medio campo con cinco defensores y un delantero agotado. Argentina pasó los siguientes treinta minutos absorbiendo la presión, observando y esperando. Cuando aparecieron los espacios, fueron letales. Llorente dijo que Inglaterra tenía los jugadores para haber tomado una decisión diferente.
• España no tomará la misma decisión. Ese fue el mensaje que Llorente transmitió en la víspera de la Final de la Copa del Mundo, con España enfrentándose a Argentina y una predicción registrada de 2-1. La mejor defensa, dijo, es defender con el balón.

Rubico Inc. Announces Letter of Intent for Acquisition of a High Specification Newbuilding MR Tanker

ATHENS, Greece, July 24, 2026 (GLOBE NEWSWIRE) — Rubico Inc. (Nasdaq: RUBI) (the “Company” or “Rubico”), a global provider of shipping transportation services specializing in the ownership of vessels, announced today it has entered into a letter of intent (the “LOI”) for the potential acquisition from Top Ships Inc., a related party controlled by Rubico’s controlling shareholder, of a shipowning company (“SPV”) that is party to a shipbuilding agreement with Guangzhou Shipyard International Company Limited for the construction of a high specification MR chemical/product oil tanker (the “Newbuilding Tanker”) to be delivered in Q2 2029. The SPV has entered into a time charter agreement with Trafigura Maritime Logistics Pte. Ltd. at a minimum fixed duration of 7 years at a time charter rate of $18,750 per day and is also party to a lease financing agreement with a Chinese Lessor for 85% of the shipbuilding price starting from the 1st instalment on a pro-rata basis without any asset cover requirement for the duration of the time charter.

Following Reopened National Advertising Division Matter, Willow Health Services Voluntarily Discontinues Claims for Compounded Semaglutide Products

In a BBB National Programs’ National Advertising Division challenge brought by Novo Nordisk Inc., Willow Health Services Inc. voluntarily discontinued certain advertising claims for its compounded semaglutide products.

In a BBB National Programs’ National Advertising Division challenge brought by Novo Nordisk Inc., Willow Health Services Inc. voluntarily discontinued certain advertising claims for its compounded semaglutide products.

WSP confirme avoir présenté à Arcadis N.V. une déclaration d’intérêt indicative non contraignante visant l’acquisition de toutes les actions émises et en circulation du capital-actions d’Arcadis N.V. moyennant un prix d’offre de 51,50 euros par action

1 Mesure financière non conforme aux IFRS ou ratio financier non conforme aux IFRS de nature prospective qui n’a pas de définition normalisée prescrite en vertu des IFRS et qui pourrait ne pas être comparable aux mesures ou aux ratios semblables utilisés par d’autres émetteurs. Voir « Mesures financières non conformes aux IFRS et autres mesures financières » et « Déclarations prospectives » ci-après.
2 L’évaluation par WSP des synergies potentielles est principalement basée sur son point de vue externe, l’expérience qu’elle a tirée d’acquisitions précédentes et l’information accessible au public et pourrait différer considérablement de ses attentes.

AI Watermarking Market Size to Surpass $5,040.94 Million by 2035, Fueled by AI Content Authentication and Copyright Protection Technologies | Research by SNS Insider

The U.S. AI Watermarking Market is expected to reach $1,334.53 Million by 2035, while Europe is projected to hit $1,170.0 Million, driven by growing AI governance regulations, digital content authentication, intellectual property protection, and enterprise adoption of AI transparency solutions.

The U.S. AI Watermarking Market is expected to reach $1,334.53 Million by 2035, while Europe is projected to hit $1,170.0 Million, driven by growing AI governance regulations, digital content authentication, intellectual property protection, and enterprise adoption of AI transparency solutions.

Blood Transfusion Diagnostics Market Size to Hit USD 8.67 Billion by 2035 as Automated Testing and AI-Driven Blood Safety Solutions Accelerate Growth | SNS Insider

U.S. Blood Transfusion Diagnostics Market to Reach USD 3.08 Billion by 2035, while Europe Blood Transfusion Diagnostics Market to Grow at 5.62% CAGR Through 2035 supported by increasing blood safety initiatives, automated diagnostic testing, and molecular screening technologies.

U.S. Blood Transfusion Diagnostics Market to Reach USD 3.08 Billion by 2035, while Europe Blood Transfusion Diagnostics Market to Grow at 5.62% CAGR Through 2035 supported by increasing blood safety initiatives, automated diagnostic testing, and molecular screening technologies.